Curis Inc reports results for the quarter ended December 31 - Earnings Summary

• Curis Inc CRIS.OQ reported a quarterly adjusted loss of $1.25​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-2.03. The mean expectation of six analysts for the quarter was for a loss of $1.36 per share. Wall Street expected results to range from $-1.72 to $-1.20 per share.

• Revenue rose 24.1% to $3.35 million from a year ago; analysts expected $2.04 million.

• Curis Inc's reported EPS for the quarter was a loss of $1.25​.

• The company reported a quarterly loss of $9.62 million.

• Curis Inc shares had fallen by 24.2% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Curis Inc is $20.00

This summary was machine generated from LSEG data March 31 at 01:47 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)